missing translation for 'onlineSavingsMsg'
Learn More

MAGEB18 Monoclonal Antibody (OTI9F9), TrueMAB™, OriGene

Mouse Monoclonal Antibody

€ 242.00 - € 540.87

Specifications

Antigen MAGEB18
Clone OTI9F9
Classification Monoclonal
Conjugate Unconjugated
Form Liquid
View More Specs

Products 2
Product Code Brand Quantity Price Quantity & Availability  
Product Code Brand Quantity Price Quantity & Availability  
17517441
Encompass_Preferred
missing translation for 'viewDocuments'
Origene Technologies
TA502648S
30 μL
€ 242.00
30µL
View alternative products
missing translation for 'toSaveUpto' 
»
Please to purchase this item. Need a web account? Register with us today!
17597431
Encompass_Preferred
missing translation for 'viewDocuments'
Origene Technologies
TA502648
100 μL
€ 540.87
100µL
View alternative products
missing translation for 'toSaveUpto' 
»
Please to purchase this item. Need a web account? Register with us today!
Description

Description

MAGEB18 Monoclonal antibody specifically detects MAGEB18 in Human, Rat samples. It is validated for Immunocytochemistry, Immunohistochemistry (Paraffin), Western Blot
Specifications

Specifications

MAGEB18
Monoclonal
Liquid
RUO
Primary
OTI9F9
Unconjugated
Mouse
IgG1
-20° C, Avoid Freeze/Thaw Cycles
Videos
SDS
Documents

Documents

Certificates
Product Content Correction

The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.